BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
16 results:

  • 1. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
    Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
    Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.
    Hu J; Hameed MR; Agaram NP; Whiting KA; Qin LX; Villano AM; O'Connor RB; Rozenberg JM; Cohen S; Prendergast K; Kryeziu S; White RL; Posner MC; Socci ND; Gounder MM; Singer S; Crago AM
    Clin Cancer Res; 2024 Jan; 30(2):450-461. PubMed ID: 37943631
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
    Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
    Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
    Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
    Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. In vitro and Pharmacoinformatics-based phytochemical screening for anticancer impacts of pistachio hull essential oil on AGS, PLC/PRF/5, and CACO2 cell lines.
    Askari N; Parvizpour S; Marashi SMB; Baghery F; Khanamani Falahati-Pour S
    Mol Biol Rep; 2023 Jan; 50(1):465-473. PubMed ID: 36348196
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
    Powell CA; Modi S; Iwata H; Takahashi S; Smit EF; Siena S; Chang DY; Macpherson E; Qin A; Singh J; Taitt C; Shire N; Camidge DR
    ESMO Open; 2022 Aug; 7(4):100554. PubMed ID: 35963179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clonal Architectures Predict Clinical Outcome in gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity.
    Ren C; Wu C; Wang N; Lian C; Yang C
    Cell Transplant; 2021; 30():963689721989606. PubMed ID: 33900127
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/β-catenin pathway.
    Wang L; Li B; Yi X; Xiao X; Zheng Q; Ma L
    Cell Prolif; 2021 Mar; 54(3):e12981. PubMed ID: 33458917
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in gastric cancer.
    Liu W; Yuan J; Liu Z; Zhang J; Chang J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986466
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.
    Bauer L; Hapfelmeier A; Blank S; Reiche M; Slotta-Huspenina J; Jesinghaus M; Novotny A; Schmidt T; Grosser B; Kohlruss M; Weichert W; Ott K; Keller G
    Ann Oncol; 2018 Jan; 29(1):127-132. PubMed ID: 29069277
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
    Werner D; Atmaca A; Pauligk C; Pustowka A; Jäger E; Al-Batran SE
    Cancer Med; 2013 Jun; 2(3):325-33. PubMed ID: 23930209
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular pathology of gastric carcinoma.
    Jang BG; Kim WH
    Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
    Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
    Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.